Prevail Therapeutics
Prevail Therapeutics is a New York City-based biotechnology company and a wholly owned subsidiary of Eli Lilly and Company.
3
Funding Rounds
$129.0m
Money raised
Overview
Prevail Therapeutics is a New York City-based biotechnology company and a wholly owned subsidiary of Eli Lilly and Company.
-
Website:
- Business model: B2C
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Prevail Therapeutics has raised a total of $129m in funding over 3 rounds.
Key Insights:
- Prevail Therapeutics Series B round, March 2019: $50m
- Prevail Therapeutics Series A round, March 8, 2018: $75m
- Prevail Therapeutics Seed round, August 1, 2017: $4m
Prevail Therapeutics Series B round, March 2019
$50m
Prevail Therapeutics Series A round, March 8, 2018
$75m
Prevail Therapeutics Seed round, August 1, 2017
$4m
Industries
Prevail Therapeutics is active in the following industries: